Purchase Order 75D30118P01933
Award Date 7/10/18
Potential Completion Date 6/30/23
Potential Value $84K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....
- This is a firm fixed price purchase order awarded by the U.S. Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for a MiSeq System. The $131,966.00 contract has a period of performance ending on July 31, 2016. Illumina has provided sequencing systems and services to various federal agencies in the past, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Illumina, Inc. for a maintenance agreement on three Illumina MiSeq sequencing instruments. The contract has a ceiling value of $42,987.00 and a period of performance through September 15, 2024. Illumina is a manufacturer of genomic sequencing and analysis solutions that has supported numerous federal agencies, including the National Institutes of Health (NIH), U.S. Department of...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The contract is for maintenance services on an unspecified range of Illumina's sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models. The contract has a ceiling value of $149,442.60 and an ultimate completion date of September 25, 2017. The contract does not have a set-aside...
- This is a $94,050.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analysis instruments and reagents. The award is for an Illumina MiSeq sequencing system and does not have a set-aside designation. Illumina has a history of providing sequencing equipment and services to support research and diagnostics across various federal agencies, including the National Institutes of Health, Department of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for preventative maintenance services on MISEQ and NOVASEQ sequencing instruments. The contract has a potential value of $125,869.80 and a completion date of November 19, 2022. Illumina has previously provided a range of sequencing systems, reagents, and services to support genomic research...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents, for the maintenance of laboratory equipment. The contract has a ceiling value of $14,329.00 and a performance period ending on July 20, 2024. The award does not utilize any set-aside provisions. Illumina has a history of providing sequencing systems, reagents, and services to support...
- This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of a MiSeq sequencing system with a one-year maintenance plan. The total potential value of the contract is $111,870.37. Illumina, a manufacturer of genomic sequencing instruments and reagents, has provided similar sequencing systems and related products to various federal agencies in the past, including the National Institutes of Health (NIH), Department of...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing and array-based analysis systems. The $42,553.12 contract is for a MiSeq Silver and iSeq 100 service agreement covering the period from September 15, 2022 to September 15, 2023. The award does not have a set-aside designation. Illumina has a history of providing sequencing platforms, reagents, and maintenance services to support genomic...